Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura

Published:2022-08-06 Issue:10 Volume:101 Page:2159-2167
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Brown Jenna^ORCID,Potugari Bindu,Mazepa Marshall A.,Kohli Ruhail,Moliterno Alison R.,Brodsky Robert A.,Vaught Jason A.,Burwick Richard,Chaturvedi Shruti

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-022-04936-2.pdf

Reference48 articles.

1. Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339(22):1585–1594

2. Falter T, Schmitt V, Herold S, Weyer V, von Auer C, Wagner S et al (2017) Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura. Transfusion 57(5):1152–1162

3. Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL et al (2015) Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood 126(25):2739–2746

4. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325(6):393–7

5. Bell WR, Braine HG, Ness PM, Kickler TS (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325(6):398–403

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consequences of unmet pregnancy-specific health care needs in women with immune TTP;Blood Vessels, Thrombosis & Hemostasis;2024-03

2. Thrombotic thrombocytopenic purpura;The Rose and Mackay Textbook of Autoimmune Diseases;2024

3. Predictors of relapse and prophylactic management of immune thrombotic thrombocytopenic purpura;Transfusion and Apheresis Science;2023-08

4. Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship;Frontiers in Medicine;2023-02-28

5. Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise;Journal of Clinical Medicine;2022-11-30